Aflac (AFL) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.59 per share. This compares to earnings of $1.58 per share a year ago.
Aflac's (AFL) Q2 results are likely to reflect the benefits of strong persistency rates in its U.S. operations, partly offset by falling net premiums in the Japan segment.
Improving business environment, underwriting practices and other factors are expected to have benefited insurance players in the second quarter. MET, AFL, AIG, ALL and EG will release earnings on Jul 31.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Aflac (AFL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
When most investors think of blue-chip stocks in today's market, big tech giants immediately come to mind. These household names have been on an incredible run, with many minting new all-time highs.
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM and TRUP.
Aflac (AFL) joins forces with SKYGEN to improve dental and vision benefit management, boosting customer satisfaction and AFL's product sales through advanced technology and streamlined processes.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes?
Aflac (AFL) collaborates with Empathy to offer grief and administrative support services to Aflac Group Life, Absence and Disability Solutions clients. This is likely to boost the sale of AFL's life insurance policies.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes?
Despite the market's dramatic sell-off on Friday, some stocks showed impressive strength by making new 52-week highs. While big tech led the market decline, these four stocks, Birkenstock, NetApp, Eli Lilly, and Aflac, demonstrated resilience and robust performance, along with displaying overall relative strength to the market and their respective sectors.